ICM Advisorysp. z o.o.
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2007-12-07
Share capital
50,000.00 PLN
Registered address
Aleja Komisji Edukacji Narodowej 47/158, 02-797 Warszawa, Poland
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2022 – the filing deadline has passed. 3 of 4 financial statements were filed late (the longest delay 946 days for 2019). 1 of 4 audited by a statutory auditor.
- 2022not filed
- 202119/05/2023
- 202022/05/2023
- 201919/05/2023
- 201812/07/2019
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2021.
Voivodeship · Mazowieckie64,146 / 142,033
Top 45%
Country · Poland232,700 / 495,860
Top 47%
Results vs industry
Revenue
This companyUSD 223.36kMedianUSD 64.65kAverageUSD 231.88k
Net profit
This companyUSD 39.89kMedianUSD 1.38kAverageUSD 38.39k
Operating costs
This companyUSD 182.74kMedianUSD 61.42kAverageUSD 191.69k
Assets
This companyUSD 202.13kMedianUSD 135.82kAverageUSD 175.04k
Industry
Authorized Representatives
Paweł Rafał Borkowski – President of the Management Board
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Paweł Rafał Borkowskiage 52 | 999 | $13,492.71 | 99.9% |
Others | 1 | $13.51 | 0.1% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2007-12-28.
91 2490 0005 0000 4610 4073 5456
67 1060 0076 0000 3200 0126 4767
51 2490 0005 0000 4530 9463 8475
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Lymelab Pharma sp. z o.o.sp. k. | $424,756.39 | lymelabpharma.com | ||
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| Codeit4us Rndsp. z o.o. | $152,435.96 | codeit4us.com | ||
| VB IdeaP.S.A. | $44,631.63 | vbidea.pl | ||
| NanovelosS.A. | $24,842.03 | nanovelos.com | ||
| Bio2materialssp. z o.o. | $14,121.59 | bio2materials.com | ||
| Nanostalsp. z o.o. | $8,607.48 | nanostal.com | ||
| IncellvuS.A. | $6,985.93 | incellvu.pl | ||
| NanotheaS.A. | $115.78 | nanothea.com |
Change history
| Date | Event | |
|---|---|---|
| 2021-01-21 | Address change (Komisji Edukacji Narodowej 21/99, 02-722, Warszawa → Aleja Komisji Edukacji Narodowej 47/158, 02-797, Warszawa) | |
| 2007-12-07 | Entered in the register |
FAQ
The company was registered in the Polish National Court Register (KRS) on December 7, 2007.
The headquarters is located at: Aleja Komisji Edukacji Narodowej 47, 02-797 Warszawa.
The management board consists of: Paweł Rafał Borkowski (President of the Management Board).
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2021 to December 31, 2021.
The company reported a revenue of $223,355 in 2021, which is an increase of 11.4% compared to 2020.
Yes, the company recorded a net profit of $39,889 in 2021.
The largest operating cost category falls under external services. This category amounted to $89,660 in 2021, representing 49% of all operating expenses.
Last updated: 2026-04-15